Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ATHX

Athersys (ATHX)

Athersys Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATHX
DateTimeSourceHeadlineSymbolCompany
01/08/20247:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
12/22/20235:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
12/21/202311:37AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
11/16/20238:35AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
10/18/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
10/16/20234:52PMBusiness WireAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesNASDAQ:ATHXAthersys Inc
10/12/20239:28AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
10/11/20239:27AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
10/10/20238:30AMBusiness WireAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with HealiosNASDAQ:ATHXAthersys Inc
10/06/20235:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
10/06/20235:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
10/03/20234:41PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
10/03/20234:30PMBusiness WireAthersys Licenses its Animal Health Assets to Ardent Animal HealthNASDAQ:ATHXAthersys Inc
10/02/20235:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
10/02/20235:04PMBusiness WireAthersys Director Jane Wasman Appointed Board ChairNASDAQ:ATHXAthersys Inc
09/25/20234:36PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATHXAthersys Inc
09/22/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ATHXAthersys Inc
09/19/202312:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
09/18/20239:35PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATHXAthersys Inc
09/18/20239:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
09/14/202311:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
09/14/202310:41AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
09/13/20235:13PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ATHXAthersys Inc
09/11/20238:46AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
09/06/20232:45PMBusiness WireGrant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney TransplantationNASDAQ:ATHXAthersys Inc
08/21/20232:36PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ATHXAthersys Inc
08/18/202310:14AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
08/17/20239:30PMBusiness WireAthersys, Inc. Announces Pricing of $3.5 Million Public OfferingNASDAQ:ATHXAthersys Inc
08/17/20234:15PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATHXAthersys Inc
08/16/20235:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
 Showing the most relevant articles for your search:NASDAQ:ATHX